Pharmaceuticals

Global Small Molecule Drug Discovery Market Size and Forecast to 2029: Revenue, Growth, and Trends

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the small molecule drug discovery market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Small Molecule Drug Discovery Market Size Today And What Will Its Value Be At The End Of 2029?

The small molecule drug discovery market size has shown significant expansion in recent years. This market is set to increase from $62.44 billion in 2024 to $67.94 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.8%. Historically, this growth can be ascribed to elements such as drug repurposing initiatives, the integration of automation in drug discovery, a rise in investment in R&D, robust regulatory support for drug development, and breakthroughs in high-throughput screening.

The small molecule drug discovery market size is projected to experience swift expansion over the coming years, reaching $104.6 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.4%. This anticipated growth during the forecast period is driven by factors such as the emergence of novel therapeutic targets, a focus on patient-centric drug discovery, the development of drug-device combination products, the use of real-world evidence, the incorporation of pharmacogenomics, and global health challenges. Key trends anticipated in this period encompass fragment-based drug discovery, the integration of artificial intelligence into drug discovery processes, RNA-targeted therapeutics, increased collaborations and partnerships, advancements in drug delivery, and the adoption of organoids and 3D cell culture models.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

Which Key Drivers Are Powering Growth In The Small Molecule Drug Discovery Market?

The small molecule drug discovery market is anticipated to expand due to the increasing prevalence of chronic diseases. These conditions are defined as lasting a year or longer, interfering with daily activities, requiring ongoing medical attention, or both. Small-molecule medications offer a treatment approach for chronic ailments such as HIV, cancer, infections, heart disease, and renal disease, often being more affordable for patients suffering from these long-term conditions. Consequently, the rising occurrence of chronic diseases is expected to stimulate the small molecule drug discovery market. A 2023 report from the National Institutes of Health (NIH), a US-based biomedical research agency, illustrates this trend, predicting that in the United States, the number of individuals aged 50 and older with at least one chronic illness will increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Moreover, the number of people with multimorbidity is projected to rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Thus, the escalating incidence of chronic diseases is a key factor driving the growth of the small molecule drug discovery market.

Which Segment Categories Are Driving Maximum Growth In The Small Molecule Drug Discovery Market?

The small molecule drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule Drugs, Biologic Drugs

2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:

1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs

2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

What Key Trends Are Driving Growth In The Small Molecule Drug Discovery Market?

A significant trend observed in the small molecule drug discovery market is the increasing adoption of technological innovations. Leading companies within this market segment are prioritizing the creation of novel products. As an example, Dotmatics, a US-based digital science platform provider, introduced its Small Molecule Drug Discovery Solution in January 2023. This solution is distinctly engineered with an integrated scientific R&D platform, offering pre-configured workflows and enhanced data management functionalities. Its purpose is to mitigate operational inefficiencies and expedite the progression of data from initial insights to final decisions.

Who Are The Leading Companies Driving The Small Molecule Drug Discovery Market?

Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Which Region Holds The Largest Share In The Small Molecule Drug Discovery Market Today?

North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp

Browse Through More Reports Similar to the Global Small Molecule Drug Discovery Market 2025, By The Business Research Company

Cardiovascular Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795